Ligustrazine Phosphate for Injection
Function and Efficacy
Ligustrazine phosphate has the effects of anti-platelet aggregation and disaggregation, dilating arterioles, improving microcirculation, increasing cerebral flow and promoting blood circulation and removing blood stasis.
Ingredients
Ligustrazine phosphate. Excipient: mannitol. Chemical name: 2,3,5,6-tetramethylpyrazine phosphate hydrate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| LigustrazinePhosphateIngredients |
Anti-platelet aggregation and disaggregation, dilate small arteries, improve microcirculation, increase cerebral flow and activate blood circulation and remove blood stasis More |
848645-86-3 | 6 |
Appearance
This product is white or off-white powder.
Indication
Used for ischemic cerebrovascular diseases, such as cerebral infarction caused by cerebral ischemia, cerebral thrombosis, and cerebral embolism.
Usage and Dosage
Intravenous drip, 50-100 mg each time, diluted in 250-500 ml of 5%-10% glucose injection or sodium chloride injection, drip slowly, preferably within 3-4 hours. Once a day, 10-15 days as a course of treatment or follow the doctor's advice.
Adverse Reactions
Stomach discomfort, dry mouth, drowsiness, etc. may occur occasionally, which can be relieved by reducing the dosage. Allergic reactions may occur occasionally.
Precautions
Patients who are allergic to this product are prohibited from using it. Patients with cerebral hemorrhage or bleeding tendency are prohibited from using it.
Drug Interactions
Not yet clear.
Storage
Keep away from light and store in a sealed container.
Packaging Specification
50mg
Manufacturer
Jincheng Haisi Pharmaceutical Co., Ltd.
-
Founded in:
1997-12-30 -
Address:
Wangtai, Jincheng City, Shanxi Province -
Tax NO.:
91140500111208832X -
Registered Funds:
148.512131 yuan -
Email: